AngioInsight, Inc. Announces the SMARTFLOW Pivotal Clinical Study
March 18, 2025
AI-Powered AngioAI+ Platform to Enhance Cardiovascular Disease Diagnosis, Including Coronary Microvascular Disease (CMD) AngioInsight, Inc., a leader in AI-driven cardiovascular solutions, announced the upcoming launch